Virtual Reality Lethal Means Safety Training

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe University of Texas at Arlington

About this trial

The goal of this randomized clinical trial is to determine whether a virtual reality (VR) training program can help healthcare providers improve their skills in discussing suicide prevention and safe storage of firearms and medications with Veterans. The study will test whether VR training increases providers' self-efficacy, confidence, and comfort in conducting lethal means safety counseling, and whether it improves their intention to use these counseling practices in their clinical work. Researchers will compare healthcare providers who complete the VR training to those who complete a 2D video training to determine whether the VR approach is more effective. Participants will complete online surveys before and after the training and again three months later. They will be randomly assigned to one of two groups: VR training group: Participants use a VR headset to interact with a virtual Veteran patient in a simulated rural clinic and practice suicide prevention counseling skills; Video training group: Participants use the same headset to watch a \~10-minute 2D video depicting the lethal means safety counseling session. After the training, participants will also provide feedback about their experience, including how realistic and useful they found the training.

Eligibility criteria

Qualifiers

Age 18 or older

healthcare providers serving rural Veterans in Texas (e.g., physicians, physician assistants, nurse practitioners, nurses, pharmacists, social workers, healthcare case managers)

English-speaking

Able to provide informed consent

Disqualifiers

Self-reported pregnancy

History of motor or balance disorders

Color blindness

Neurological or cognitive disorders

Trial design

Treatments tested in this trial

  • Virtual Reality Lethal Means Safety Training
  • 2D Video Training

Treatment groups

36 Participants
are divided into 2 treatment groups

Sponsors and collaborators

The University of Texas at Arlington

Lead sponsor

American Foundation for Suicide Prevention

Collaborator